These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19338662)
21. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989 [TBL] [Abstract][Full Text] [Related]
22. Variability of in situ proteomic profiling and implications for study design in colorectal tumors. Li JQ; Xu BJ; Shakhtour B; Deane N; Merchant N; Heslin MJ; Washington K; Coffey RJ; Beauchamp RD; Shyr Y; Billheimer D Int J Oncol; 2007 Jul; 31(1):103-11. PubMed ID: 17549410 [TBL] [Abstract][Full Text] [Related]
23. The cancer cell secretome: a good source for discovering biomarkers? Pavlou MP; Diamandis EP J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844 [TBL] [Abstract][Full Text] [Related]
24. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry. Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444 [TBL] [Abstract][Full Text] [Related]
25. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392 [TBL] [Abstract][Full Text] [Related]
26. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081 [TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines. Ying-Tao Z; Yi-Ping G; Lu-Sheng S; Yi-Li W Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):725-32. PubMed ID: 15947549 [TBL] [Abstract][Full Text] [Related]
28. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Paweletz CP; Liotta LA; Petricoin EF Urology; 2001 Apr; 57(4 Suppl 1):160-3. PubMed ID: 11295617 [TBL] [Abstract][Full Text] [Related]
29. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology]. Espejel F; Roa JC Med Clin (Barc); 2008 Sep; 131(8):312-7. PubMed ID: 18803927 [TBL] [Abstract][Full Text] [Related]
30. [Proteomics and biomarkers for detection of endometrial carcinoma]. Kacerovský M; Tosner J Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981 [TBL] [Abstract][Full Text] [Related]
31. Proteomics of breast cancer for marker discovery and signal pathway profiling. Hondermarck H; Vercoutter-Edouart AS; Révillion F; Lemoine J; el-Yazidi-Belkoura I; Nurcombe V; Peyrat JP Proteomics; 2001 Oct; 1(10):1216-32. PubMed ID: 11721634 [TBL] [Abstract][Full Text] [Related]
32. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Wu C; Luo Z; Chen X; Wu C; Yao D; Zhao P; Liu L; Shi B; Zhu L Oncol Rep; 2009 Jun; 21(6):1429-37. PubMed ID: 19424620 [TBL] [Abstract][Full Text] [Related]
33. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Chen EI; Hewel J; Felding-Habermann B; Yates JR Mol Cell Proteomics; 2006 Jan; 5(1):53-6. PubMed ID: 16272560 [TBL] [Abstract][Full Text] [Related]
34. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer. Ma H; Chen G; Guo M Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366 [TBL] [Abstract][Full Text] [Related]
35. MALDI mass spectrometry in prostate cancer biomarker discovery. Flatley B; Malone P; Cramer R Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156 [TBL] [Abstract][Full Text] [Related]
36. Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Zhang YT; Geng YP; Zhou L; Lai BC; Si LS; Wang YL World J Gastroenterol; 2005 Aug; 11(30):4679-84. PubMed ID: 16094709 [TBL] [Abstract][Full Text] [Related]
37. Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Tainsky MA Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210 [TBL] [Abstract][Full Text] [Related]
38. Predictive biomarkers of colorectal cancer. Ding D; Han S; Zhang H; He Y; Li Y Comput Biol Chem; 2019 Dec; 83():107106. PubMed ID: 31542707 [TBL] [Abstract][Full Text] [Related]
39. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229 [TBL] [Abstract][Full Text] [Related]
40. Proteomic evaluation of core biopsy specimens from breast lesions. Bisca A; D'Ambrosio C; Scaloni A; Puglisi F; Aprile G; Piga A; Zuiani C; Bazzocchi M; Di Loreto C; Paron I; Tell G; Damante G Cancer Lett; 2004 Feb; 204(1):79-86. PubMed ID: 14744537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]